US Stock MarketDetailed Quotes
TLIS Talis Biomedical
- 1.690
- 0.0000.00%
15min DelayClose Oct 25 16:00 ET
3.08MMarket Cap-60P/E (TTM)
1.790High1.690Low5.21KVolume1.790Open1.690Pre Close8.81KTurnover0.45%Turnover RatioLossP/E (Static)1.82MShares9.60052wk High0.06P/B1.97MFloat Cap1.37052wk Low--Dividend TTM1.16MShs Float508.500Historical High--Div YieldTTM5.92%Amplitude1.370Historical Low1.691Avg Price1Lot Size
Talis Biomedical Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -39.04%59.87M | -37.73%70.34M | -41.06%76.73M | -41.06%76.73M | -38.80%88M | -40.62%98.2M | -39.78%112.96M | -44.01%130.19M | -44.01%130.19M | -47.45%143.78M |
| -Cash and cash equivalents | -39.04%59.87M | -37.73%70.34M | -41.06%76.73M | -41.06%76.73M | -38.80%88M | -40.62%98.2M | -39.78%112.96M | -44.01%130.19M | -44.01%130.19M | -47.45%143.78M |
| Receivables | --0 | -95.28%6K | -83.77%50K | -83.77%50K | -98.85%5K | -16.35%532K | -95.11%127K | 68.31%308K | 68.31%308K | 97.72%433K |
| -Accounts receivable | --0 | -95.28%6K | -83.77%50K | -83.77%50K | -98.85%5K | -16.35%532K | -95.11%127K | 68.31%308K | 68.31%308K | --433K |
| Inventory | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.03M |
| Restricted cash | ---- | ---- | ---- | ---- | ---- | --1.01M | --1.01M | ---- | ---- | ---- |
| Other current assets | 67.97%3.73M | -44.57%827K | -67.62%901K | -67.62%901K | -62.97%1.53M | -61.26%2.22M | -79.10%1.49M | -17.83%2.78M | -17.83%2.78M | 47.80%4.13M |
| Total current assets | -37.62%63.6M | -38.43%71.17M | -41.72%77.68M | -41.72%77.68M | -40.46%89.53M | -41.39%101.97M | -42.44%115.59M | -43.55%133.28M | -43.55%133.28M | -45.82%150.38M |
| Non current assets | ||||||||||
| Net PPE | -57.42%8.33M | -38.57%9.78M | -54.87%15.45M | -54.87%15.45M | -61.48%16.15M | -57.41%19.57M | -32.12%15.92M | 46.07%34.23M | 46.07%34.23M | 76.29%41.94M |
| -Gross PPE | -57.42%8.33M | -38.57%9.78M | -39.66%28.39M | -39.66%28.39M | -61.48%16.15M | -57.41%19.57M | -32.12%15.92M | 71.56%47.05M | 71.56%47.05M | 76.29%41.94M |
| -Accumulated depreciation | ---- | ---- | -0.95%-12.94M | -0.95%-12.94M | ---- | ---- | ---- | -221.19%-12.82M | -221.19%-12.82M | ---- |
| Other non current assets | -50.32%766K | 0.00%1.54M | -13.18%1.54M | -13.18%1.54M | -13.18%1.54M | -13.18%1.54M | -75.55%1.54M | -71.71%1.78M | -71.71%1.78M | 1.60%1.78M |
| Total non current assets | -56.90%9.1M | -35.16%11.32M | -52.81%16.99M | -52.81%16.99M | -59.52%17.7M | -55.76%21.11M | -41.32%17.47M | 21.19%36.01M | 21.19%36.01M | 71.18%43.72M |
| Total assets | -40.93%72.7M | -38.00%82.49M | -44.08%94.67M | -44.08%94.67M | -44.75%107.23M | -44.48%123.08M | -42.30%133.05M | -36.32%169.29M | -36.32%169.29M | -35.96%194.09M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 52.15%3.79M | -6.51%3.62M | -64.46%1.34M | -64.46%1.34M | -34.40%2.7M | -37.38%2.49M | -26.45%3.87M | -26.43%3.77M | -26.43%3.77M | -23.70%4.11M |
| -accounts payable | 52.15%3.79M | -6.51%3.62M | -64.46%1.34M | -64.46%1.34M | -34.40%2.7M | -37.38%2.49M | -26.45%3.87M | -26.43%3.77M | -26.43%3.77M | -23.70%4.11M |
| Current accrued expenses | -32.41%634K | -38.54%992K | -27.70%715K | -27.70%715K | -19.26%637K | -39.09%938K | -33.08%1.61M | -81.35%989K | -81.35%989K | -95.42%789K |
| Current debt and capital lease obligation | 6.83%2.92M | -2.03%2.9M | -22.17%2.88M | -22.17%2.88M | -4.47%2.86M | 17.22%2.74M | 81.94%2.96M | 200.57%3.7M | 200.57%3.7M | 166.22%3M |
| -Current capital lease obligation | 6.83%2.92M | -2.03%2.9M | -22.17%2.88M | -22.17%2.88M | -4.47%2.86M | 17.22%2.74M | 81.94%2.96M | 200.57%3.7M | 200.57%3.7M | 166.22%3M |
| Current liabilities | -11.51%8.2M | -15.29%9.47M | -30.78%8.77M | -30.78%8.77M | -25.73%8.45M | -33.38%9.26M | -26.81%11.18M | -33.68%12.67M | -33.68%12.67M | -63.70%11.38M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -10.04%15.88M | 39.07%16.34M | -43.82%16.79M | -43.82%16.79M | -43.22%17.22M | -42.64%17.65M | -6.20%11.75M | 134.44%29.88M | 134.44%29.88M | 133.99%30.33M |
| -Long term capital lease obligation | -10.04%15.88M | 39.07%16.34M | -43.82%16.79M | -43.82%16.79M | -43.22%17.22M | -42.64%17.65M | -6.20%11.75M | 134.44%29.88M | 134.44%29.88M | 133.99%30.33M |
| Total non current liabilities | -10.04%15.88M | 39.07%16.34M | -43.82%16.79M | -43.82%16.79M | -43.22%17.22M | -42.64%17.65M | -6.20%11.75M | 134.44%29.88M | 134.44%29.88M | 133.99%30.33M |
| Total liabilities | -10.54%24.07M | 12.56%25.81M | -39.94%25.56M | -39.94%25.56M | -38.45%25.67M | -39.76%26.91M | -17.53%22.93M | 33.59%42.55M | 33.59%42.55M | -5.86%41.71M |
| Shareholders'equity | ||||||||||
| Share capital | 0.00%3K | -50.00%3K | 0.00%3K | 0.00%3K | -50.00%3K | -50.00%3K | 0.00%6K | -50.00%3K | -50.00%3K | 20.00%6K |
| -common stock | --0 | --0 | --0 | --0 | --0 | --0 | 0.00%3K | --0 | --0 | 50.00%3K |
| -Preferred stock | 0.00%3K | 0.00%3K | 0.00%3K | 0.00%3K | 0.00%3K | 0.00%3K | 0.00%3K | 0.00%3K | 0.00%3K | 0.00%3K |
| Retained earnings | -9.99%-561.85M | -11.54%-553M | -12.97%-539.96M | -12.97%-539.96M | -16.73%-526.5M | -20.19%-510.82M | -24.57%-495.79M | -30.97%-477.95M | -30.97%-477.95M | -34.12%-451.03M |
| Paid-in capital | 0.57%610.47M | 0.62%609.68M | 0.72%609.07M | 0.72%609.07M | 0.77%608.05M | 0.82%606.98M | 0.85%605.9M | 0.96%604.69M | 0.96%604.69M | 1.40%603.41M |
| Total stockholders'equity | -49.44%48.63M | -48.53%56.68M | -45.47%69.12M | -45.47%69.12M | -46.48%81.56M | -45.67%96.17M | -45.69%110.12M | -45.83%126.74M | -45.83%126.74M | -41.12%152.39M |
| Total equity | -49.44%48.63M | -48.53%56.68M | -45.47%69.12M | -45.47%69.12M | -46.48%81.56M | -45.67%96.17M | -45.69%110.12M | -45.83%126.74M | -45.83%126.74M | -41.12%152.39M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data